Artificial tears: Clinical Trials

9 trials of Artificial tears, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed. 9 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 49Completed 9

Follow Artificial tears: new trials by email Literature Review of Artificial tears trials Research Report on Artificial tears

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Topical Insulin for Ocular Surface Interface in Dry Eye Disease
Artificial tear, insulin human - Dry Eye, Insulin Sensitivity
Phase 4CompletedKhyber Teaching Hospital1282025-04-142026-08-14
Clinical Trial To Determine The Effectiveness And Safety Of Topical Insulin In Dry Eye
Insulin, Cyclosporins, Artificial tears - Dry Eye, Insulin
Phase 4CompletedBarbara Burgos Blasco1162022-10-192026-03-05
Control of Pain in Intravitreal Injections Using Topical NSAIDs
Bromfenac, Artificial tears - Intravitreal Injections, IVI
Phase 4CompletedUniversity of Wisconsin, Madison462019-06-272023-06-12
Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy
Brinzolamide/Brimonidine FC, Brimonidine 0.2%, Artificial tears - Posterior Capsule Opacification, Ocular Hypertension
Phase 4CompletedUniversity Hospital of Patras792016-06-202019-07-16
Tear Osmolarity Changes After Instilling Isotonic Hyaluronate Artificial Tears
Artificial tears - Dry Eye
Phase 4CompletedThomas O Salmon, OD, PhD82012-06-012020-04-03
Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis
Loteprednol/tobramycin, Loteprednol, B+L Advanced Eye Relief Lubricant Drop - Meibomian Gland Dysfunction, Posterior Blepharitis
Phase 4CompletedMassachusetts Eye and Ear Infirmary602011-08-012017-08-01
Steroids After Laser Trabeculoplasty for Glaucoma
Prednisolone 1%, Ketorolac, Artificial Tears - Glaucoma
Phase 4CompletedStanford University972009-09-012019-08-07
Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model
Prednisolone Acetate 1%, Prednisolone Acetate 0.12%, Loteprednol Etabonate 0.2% - Allergic Conjunctivitis
Phase 4CompletedORA, Inc.362008-05-012020-09-02
A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis
Olopatadine, Fluticasone, Saline - Conjunctivitis, Allergic
Phase 4CompletedGreiner, Jack V., OD DO PhD602008-02-012008-04-09

Conditions studied

Dry Eye Syndromes (4)  ·  Conjunctivitis, Allergic (2)  ·  Insulin Resistance (2)  ·  Blepharitis (1)  ·  Glaucoma (1)  ·  Meibomian Gland Dysfunction (1)  ·  Ocular Hypertension (1)  ·  Pain (1)

Sponsors

Barbara Burgos Blasco (1)  ·  Greiner, Jack V., OD DO PhD (1)  ·  Khyber Teaching Hospital (1)  ·  Massachusetts Eye and Ear Infirmary (1)  ·  ORA, Inc. (1)  ·  Stanford University (1)  ·  Thomas O Salmon, OD, PhD (1)  ·  University Hospital of Patras (1)  ·  University of Wisconsin, Madison (1)

Countries

United States (6)  ·  Greece (1)  ·  Pakistan (1)  ·  Spain (1)

Top investigators

Barbara Burgos Blasco, MD, PhD (1)  ·  Constantinos Georgakopoulos, MD, PhD (1)  ·  Gail L Torkildsen, MD (1)  ·  Jack V Greiner, OD, DO, PhD (1)  ·  Jeffrey L Goldberg, MD, PhD (1)  ·  Maxwell Wingelaar, MD (1)  ·  Mihai Mititelu, MD, MPH (1)  ·  Reza Dana, MD, MPH, MSc (1)  ·  Shafiq Tanvee, MBBS, FCPS (1)  ·  Thomas O Salmon, OD, PhD (1)

Results publications

PMID 30802601